RNA实时信号 | 通过Getagraph.com最大化利润

购买 107368 min ago

@ $13.56

发出时间: 15 Feb 2024 @ 03:05

回报率: 79.65%

上一信号: Feb 14 - 04:50

上一信号: 出售

回报率: 1.88 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	1.03M
平均成交量	1.16M
市值	1.94B
EPS	$0 ( 2024-02-27 )
下一个收益日期	( $-0.810 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.37
ATR14	$0.0240 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Levin Arthur A	Sell	5 000	Stock Option (Right to Buy)
2024-04-19	Levin Arthur A	Buy	5 000	Common Stock
2024-04-19	Levin Arthur A	Sell	5 000	Common Stock
2024-04-03	Levin Arthur A	Sell	20 000	Common Stock
2024-04-02	Boyce Sarah	Sell	28 000	Stock Option (Right to Buy)

INSIDER POWER
24.58
Last 100 transactions
Buy: 3 077 200 \| Sell: 1 623 052

音量相关性

長: 0.31 (neutral)

短: 0.25 (neutral)

Signal:(63.936) Neutral

Avidity Biosciences Inc 相关性

10 最正相关
RENT	0.957
RXDX	0.944
VBNK	0.942
TACO	0.933
GLRE	0.931
MOMO	0.93
ICVX	0.929
MLVF	0.929
ACAD	0.926
HAPP	0.925

10 最负相关
PIII	-0.937
SMFL	-0.936
SPCX	-0.928
SYBT	-0.925
LUCD	-0.921
TRIT	-0.916
THFF	-0.914
UCBI	-0.913
VORB	-0.912
BCAB	-0.912

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Avidity Biosciences Inc 相关性 - 货币/商品

-0.44
( neutral )

-0.30
( neutral )

0.00
( neutral )

-0.64
( weak negative )

0.18
( neutral )

0.39
( neutral )

Avidity Biosciences Inc 财务报表

Annual	2023
营收:	$9.56M
毛利润:	$7.46M (78.02 %)
EPS:	$-2.91

FY	2023
营收:	$9.56M
毛利润:	$7.46M (78.02 %)
EPS:	$-2.91

FY	2022
营收:	$9.22M
毛利润:	$7.84M (84.96 %)
EPS:	$-3.24

FY	2021
营收:	$9.33M
毛利润:	$0.00 (0.00 %)
EPS:	$-2.73

Financial Reports:

No articles found.

Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.